<i>MMP12,</i> Lung Function, and COPD in High-Risk Populations

Gary M. Hunninghake(Center for Genomic Science), Michael H. Cho(Harvard University), Yohannes Tesfaigzi(Lovelace Respiratory Research Institute), Manuel E. Soto-Quirós(Hospital Nacional de Niños), Lydiana Ávila(Hospital Nacional de Niños), Jessica Lasky‐Su(Center for Genomic Science), Chris A. Stidley(Lovelace Respiratory Research Institute), Erik Melén(Center for Genomic Science), Cilla Söderhäll, Jenny Hallberg(Sachs' Children and Youth Hospital), Inger Kull, Juha Kere, Magnus Svartengren(Karolinska Institutet), Göran Pershagen, Magnus Wickman(Sachs' Children and Youth Hospital), Christoph Lange(Center for Genomic Science), Dawn L. DeMeo(Harvard University), Craig P. Hersh(Center for Genomic Science), Barbara J. Klanderman(Harvard University), Benjamin A. Raby(Center for Genomic Science), David Sparrow(VA Boston Healthcare System), Steven D. Shapiro(University of Pittsburgh), Edwin K. Silverman(Harvard University), Augusto A. Litonjua(Brigham and Women's Hospital), Scott T. Weiss(Harvard University), Juan C. Celedón(Center for Genomic Science)
New England Journal of Medicine
December 17, 2009
Cited by 375Open Access
Full Text

Abstract

BACKGROUND: Genetic variants influencing lung function in children and adults may ultimately lead to the development of chronic obstructive pulmonary disease (COPD), particularly in high-risk groups. METHODS: We tested for an association between single-nucleotide polymorphisms (SNPs) in the gene encoding matrix metalloproteinase 12 (MMP12) and a measure of lung function (prebronchodilator forced expiratory volume in 1 second [FEV(1)]) in more than 8300 subjects in seven cohorts that included children and adults. Within the Normative Aging Study (NAS), a cohort of initially healthy adult men, we tested for an association between SNPs that were associated with FEV(1) and the time to the onset of COPD. We then examined the relationship between MMP12 SNPs and COPD in two cohorts of adults with COPD or at risk for COPD. RESULTS: The minor allele (G) of a functional variant in the promoter region of MMP12 (rs2276109 [-82A-->G]) was positively associated with FEV(1) in a combined analysis of children with asthma and adult former and current smokers in all cohorts (P=2x10(-6)). This allele was also associated with a reduced risk of the onset of COPD in the NAS cohort (hazard ratio, 0.65; 95% confidence interval [CI], 0.46 to 0.92; P=0.02) and with a reduced risk of COPD in a cohort of smokers (odds ratio, 0.63; 95% CI, 0.45 to 0.88; P=0.005) and among participants in a family-based study of early-onset COPD (P=0.006). CONCLUSIONS: The minor allele of a SNP in MMP12 (rs2276109) is associated with a positive effect on lung function in children with asthma and in adults who smoke. This allele is also associated with a reduced risk of COPD in adult smokers.


Related Papers

No related papers found

Powered by citation graph analysis